Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
3.85
-0.03 (-0.77%)
At close: May 23, 2025, 3:04 PM
3.85
0.00%
After-hours: May 23, 2025, 03:04 PM EDT
-0.77% (1D)
| Bid | 3.61 |
| Market Cap | 181.18M |
| Revenue (ttm) | 42.2M |
| Net Income (ttm) | -33.47M |
| EPS (ttm) | -1.62 |
| PE Ratio (ttm) | -2.37 |
| Forward PE | -22.71 |
| Analyst | Buy |
| Ask | 3.93 |
| Volume | 64 |
| Avg. Volume (20D) | 11,296 |
| Open | 3.75 |
| Previous Close | 3.88 |
| Day's Range | 3.75 - 3.85 |
| 52-Week Range | 2.76 - 7.29 |
| Beta | 1.52 |
About NBTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+18.51%
Nanbotix shares are trading higher after the compa...
Unlock content with
Pro Subscription
4 months ago
+7.26%
Nanobiotix shares are trading higher after the company announced it began its Phase 2 trial for an innovative cancer treatment in stage 3 lung cancer.
